BIOLINERX LTD-SPONS ADR (BLRX) Stock Cash Flow
NASDAQ:BLRX - Nasdaq - US09071M2052 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.22M | -60.61M | -24.95M | -27.05M | -30.02M | |||
| Depreciation Amortization | 4.07M | 1.38M | 654.00K | 703.00K | 934.00K | |||
| Change In Working Capital | -21.82M | 15.20M | 1.24M | -540.00K | -1.29M | |||
| Interest Paid | 10.39M | 1.11M | 593.00K | 682.00K | 994.00K | |||
| Other non cash items | -16.90M | 21.42M | -3.18M | 3.32M | 7.17M | |||
| OPERATING CASH FLOW | -43.87M | -22.61M | -26.24M | -23.57M | -23.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -54.00K | -297.00K | -316.00K | -97.00K | 0.00 | |||
| Other Investing Activity | 29.43M | 1.74M | 4.32M | -38.13M | 16.67M | |||
| INVESTING CASH FLOW | 29.37M | 1.44M | 4.01M | -38.22M | 16.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.28M | -1.99M | 6.07M | -3.57M | -3.36M | |||
| Stock Issued/Repurchased | 16.38M | 17.04M | 14.36M | 61.32M | 21.22M | |||
| FINANCING CASH FLOW | 20.66M | 15.06M | 20.44M | 57.75M | 17.87M | |||
| Exchange Rate Effect | 22.00K | -224.00K | -607.00K | 207.00K | 206.00K | |||
| CHANGE IN CASH | 6.18M | -6.33M | -2.40M | -3.84M | 11.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -43.87M | -22.61M | -26.24M | -23.57M | -23.21M | |||
| Capital Expenditure | -54.00K | -297.00K | -316.00K | -97.00K | 0.00 | |||
| FREE CASH FLOW | -43.93M | -22.91M | -26.56M | -23.67M | -23.21M | |||
All data in USD